2015-09-05 1500 PT - News Release
VP Close 2015-09-04 C$ 0.095
Mr. Otto Folprecht reports
VODIS APPOINTS TAMMY GILLIS AS NEW CHIEF FINANCIAL OFFICER
September 5, 2015- Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV /Q:VDQSF) (“Vodis” or “the Company”) is pleased that effective September 1, 2015, Tammy Gillis, CPA, CMA, has been appointed as Chief Financial Officer.
Tammy Gillis is a CPA, CMA with over 15 years of experience in finance, reporting and regulatory requirements for both private and publicly traded companies. Ms. Gillis started her career working at a corporate and securities law firm and has experience in manufacturing, resource exploration and high-tech companies trading on the TSX and TSX Venture Exchange.
In connection with the appointment of Tammy Gillis to CFO, the Company has granted stock options to purchase 200,000 shares, exercisable at a price of $0.10 per share for a period of five years.
Brian Gusko will step down as CFO but will remain with the Company in an advisory role. Management and the Board of Directors would like to thank Mr. Gusko for his hard work and contributions to the Company.
Vodis is one of Canada’s foremost brand names in the medical marijuana business. Its master grow teams have consistently won or placed at each competition they have entered with their “VIP” brand. The Company, with facilities in BC and Washington State, is also actively looking into expansion opportunities in other countries and US states.
VODIS PHARMACEUTICALS INC.
Otto Folprecht, CEO & Director
For information with respect to the Company or the contents of this news release, please contact Richard Schnoor, Head of Corporate Communications at 1-866-210-1420 ext. 110, or visit the web site at www.vodis.ca
Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expects” or “it is expected”, or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including: the receipt of all necessary regulatory approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statements or forward-looking information that is incorporated by reference herein, except as required by applicable securities laws.
THE CANADIAN SECURITES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
- Page 1 of 74